| Literature DB >> 18481016 |
Tae Chul Moon1, Chang Seob Seo, Kyungmi Haa, Jin Cheul Kim, Nam Kyung Hwang, Tae Gyun Hong, Jee Hyeun Kim, Do Hun Kim, Jong Keun Son, Hyeun Wook Chang.
Abstract
Meso-dihydroguaiaretic acid (MDGA) is a medicinal herbal product isolated from the aerial parts of Saururus chinensis that inhibits the cyclooxygenase-2 (COX-2)-dependent phase of prostaglandin D(2) (PGD(2)) generation in bone marrow-derived mast cells (BMMC) (IC(50) 9.8 microM). However, this compound did not inhibit COX-2 protein expression in BMMC at concentrations up to 30 microM, indicating that MDGA directly inhibits COX-2 activity. In addition, this compound consistently inhibited the production of leukotriene C(4) (IC(50) 1.3 microM). These results demonstrate that MDGA inhibits both COX-2 and 5-lipoxygenase. Furthermore, this compound strongly inhibited the degranulation reaction in BMMC (IC(50) 11.4 microM). Therefore, this compound might provide a basis for novel anti-inflammatory drug development.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18481016 DOI: 10.1007/s12272-001-1200-y
Source DB: PubMed Journal: Arch Pharm Res ISSN: 0253-6269 Impact factor: 4.946